Anghelina Mirela, Moldovan Leni, Moldovan Nicanor I
Davis Heart and Lung Research Institute, Division of Cardiology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio 43210, USA.
J Cell Mol Med. 2005 Jan-Mar;9(1):113-21. doi: 10.1111/j.1582-4934.2005.tb00341.x.
The tyrosine kinase Tie2/Tek (the receptor for angiopoietins) is considered one of the most reliable markers of the endothelial phenotype, across organisms, organs, and developmental stages. However, endothelium is intrinsically heterogeneous in origin, composition and function, presenting an arteriolar/venular asymmetry. In this regard, the expression of Tie2 along the vascular tree, although thought to be homogenous, has not been systematically investigated. Therefore we questioned whether the activity of Tie2 promoter is uniform in the microvascular endothelium. To this end, we analyzed in situ the expression of the markers beta-galactosidase [LacZ(Tie2)] and green fluorescent protein (GFP) [GFP(Tie2)], placed under the Tie2 promoter in transgenic mice, in whole mount tissue samples, which allow the simultaneous evaluation of its relative distribution in various microvascular compartments. In the mesenteries of LacZ(Tie2) and GFP(Tie2) mice, we found that the activity of Tie2 promoter is asymmetrically distributed, being much stronger in arteries and arterioles than on the venular side of the vascular tree. This observation was replicated in the diaphragm of LacZ(Tie2) mice. The capillaries presented a mosaic pattern of Tie2 promoter activity. Stimulation of angiogenesis either by wounding, or by intraperitoneal injection of Vascular Endothelial Growth Factor (VEGF), revealed that the arteriolar/venular asymmetry is established at endothelial cellular level early during new capillary formation, even before the starting of the microvascular blood flow. In conclusion, a strong Tie2 promoter activity qualifies as a novel marker of the arteriolar phenotype in microvascular endothelium.
酪氨酸激酶Tie2/Tek(血管生成素的受体)被认为是跨生物体、器官和发育阶段的内皮细胞表型最可靠的标志物之一。然而,内皮细胞在起源、组成和功能上本质上是异质性的,呈现出小动脉/小静脉的不对称性。在这方面,尽管人们认为Tie2在整个血管树中的表达是均匀的,但尚未进行系统研究。因此,我们质疑Tie2启动子的活性在微血管内皮细胞中是否一致。为此,我们在转基因小鼠中分析了置于Tie2启动子控制下的β-半乳糖苷酶[LacZ(Tie2)]和绿色荧光蛋白(GFP)[GFP(Tie2)]标记物在整装组织样本中的原位表达,这种样本可同时评估其在各种微血管腔室中的相对分布。在LacZ(Tie2)和GFP(Tie2)小鼠的肠系膜中,我们发现Tie2启动子的活性呈不对称分布,在动脉和小动脉中比在血管树的静脉侧要强得多。这一观察结果在LacZ(Tie2)小鼠的膈肌中得到了重复。毛细血管呈现出Tie2启动子活性的镶嵌模式。通过创伤或腹腔注射血管内皮生长因子(VEGF)刺激血管生成,结果显示,即使在微血管血流开始之前,小动脉/小静脉的不对称性在新毛细血管形成的早期内皮细胞水平就已确立。总之,强烈的Tie2启动子活性可作为微血管内皮细胞中小动脉表型的一种新标志物。